Search Results - "Aslanis, V."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline taxane-based chemotherapy

    Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline taxane-based chemotherapy by CAMPONE, M, CORTES-FUNES, H, ASLANIS, V, FUMOLEAU, P, VOROBIOF, D, MARTIN, M, SLABBER, C. F, CIRUELOS, E, BOURBOULOUX, E, MENDIOLA, C, DELGADO, F. M, COLIN, C

    Published in British journal of cancer (06-11-2006)
    “…To evaluate the single agent activity, pharmacokinetics and tolerability of the novel tubulin targeted agent vinflunine (VFL) (320 mg m(-2) q 21 days) as…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Cabozantinib in Asian patients with hepatocellular carcinoma and other solid tumours: Population pharmacokinetics analysis

    Cabozantinib in Asian patients with hepatocellular carcinoma and other solid tumours: Population pharmacokinetics analysis by Hsu, C.-H., Nguyen, L., Cheng, A.-L., Nguyen, T.X.Q., Brendel, K., Aslanis, V., Benzaghou, F.

    Published in Annals of oncology (01-11-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    1460P GALLANT-1: GB1211 galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC)

    1460P GALLANT-1: GB1211 galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) by Aparisi Aparisi, F.D.A., Felip, E., Pichon, E., Carcereny, E., Barre, P., Raumlau, R., Sethi, T., Lindmark, B., Slack, R., MacKinnon, A., Aslanis, V., Phung, D., Jensen, P., Rajiwate, Z., Ross, G., Basse, L., Ghiringhelli, F.

    Published in Annals of oncology (01-10-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    1192TiP GALLANT-1: Galectin-3 (Gal-3) inhibitor, GB1211, plus atezolizumab (atz) in patients (pts) with non-small cell lung cancer (NSCLC) - a dose finding study followed by a randomised, double-blind, placebo-controlled trial

    1192TiP GALLANT-1: Galectin-3 (Gal-3) inhibitor, GB1211, plus atezolizumab (atz) in patients (pts) with non-small cell lung cancer (NSCLC) - a dose finding study followed by a randomised, double-blind, placebo-controlled trial by Ghiringhelli, F., Barre, P., Pichon, E., Ponce Aix, S., Juan Vidal, O.J., Carcereny Costa, E., Sethi, T., Lindmark, B., MacKinnon, A., Aslanis, V., Phung, D.H., Jensen, P., Rajiwate, Z., Ross, G., Basse, L.

    Published in Annals of oncology (01-09-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Phase I dose-escalation study of oral vinflunine given twice a day for 2 consecutive days every week in patients with solid tumours

    Phase I dose-escalation study of oral vinflunine given twice a day for 2 consecutive days every week in patients with solid tumours by Bennouna, J., Vermorken, J. B., Senellart, H., Valverde, C., Altintas, S., Aslanis, V., Brandely, M., Calvo-Aller, E.

    Published in Journal of clinical oncology (20-05-2008)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Phase I and pharmacokinetic study of vinflunine (VFL) in combination with carboplatin (CBDCA) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Final results

    Phase I and pharmacokinetic study of vinflunine (VFL) in combination with carboplatin (CBDCA) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Final results by Tourani, J.-M., Pinel, M.-C., Planchard, D., Aslanis, V., Gouva, S., Robinet, G.

    Published in Journal of clinical oncology (01-06-2005)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: